Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.39 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20047177 | 0.91 | L3MBTL1 (0.46) | MEN1KMT2AAKR1C3CHRM5CHRM1 | |
| SCHEMBL20047029 | 0.89 | CYP11B1 (0.50) | CYP11B1CYP11B2 | |
| SCHEMBL20047024 | 0.88 | CHRM5 (0.41) | MEN1KMT2AAKR1C3AKR1C1CHRM5 | |
| SCHEMBL20047027 | 0.83 | PKM (0.51) | MEN1KMT2AAKR1C3AKR1C1ESR2 | |
| SCHEMBL20047021 | 0.82 | AKR1C3 (0.45) | MEN1KMT2AAKR1C3AKR1C1CHRM5 | |
| SCHEMBL20047032 | 0.82 | KMT2A (0.47) | MEN1KMT2AAKR1C3AKR1C1ESR2 | |
| SCHEMBL20047019 | 0.80 | MEN1 (0.40) | MEN1KMT2AAKR1C3AKR1C1CHRM5 | |
| SCHEMBL20047022 | 0.80 | MEN1 (0.43) | MEN1KMT2AAKR1C3AKR1C1CHRM5 | |
| SCHEMBL20047023 | 0.80 | AKR1C3 (0.49) | MEN1KMT2AAKR1C3AKR1C1CYP11B1 | |
| SCHEMBL20047025 | 0.80 | CHRM5 (0.38) | MEN1KMT2AAKR1C3AKR1C1CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017223514-A9 | LXR INVERSE AGONISTS FOR TREATMENT OF CANCER | SAINT LOUIS UNIVERSITY (US) | 2018-04-12 | — | — | WO | disclosed |